Greystone Financial Group LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 5,395 shares of the exchange traded fund’s stock, valued at approximately $658,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of XBI. Davis Capital Management acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $35,000. Barnes Dennig Private Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $48,000. Halbert Hargrove Global Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at $40,000. Premier Financial Group bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at $50,000. Finally, Family CFO Inc acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $64,000.
SPDR S&P Biotech ETF Trading Down 0.6%
Shares of SPDR S&P Biotech ETF stock opened at $137.79 on Tuesday. The business has a 50-day moving average price of $126.58 and a two-hundred day moving average price of $121.26. SPDR S&P Biotech ETF has a 1-year low of $74.67 and a 1-year high of $139.19. The company has a market cap of $9.09 billion, a P/E ratio of 11.47 and a beta of 0.88.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
